In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products

(2010) Raymond P. Goodrich et al.   BIOLOGICALS

The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

(2010) Brian Custer et al.   TRANSFUSION

Noninfectious Serious Hazards of Transfusion

(2009) Jeanne E. Hendrickson et al.   ANESTHESIA AND ANALGESIA

Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC

(2009) N.A. Mufti et al.   BIOLOGICALS

Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

(2009) E. C. Vamvakas et al.   BLOOD

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins

(2009) Valerie S. Hornsey et al.   TRANSFUSION

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

(2009) James Smith et al.   TRANSFUSION

The influence of riboflavin photochemistry on plasma coagulation factors

(2009) Luis Larrea et al.   TRANSFUSION AND APHERESIS SCIENCE

Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications

(2008) Philip C. Spinella   CRITICAL CARE MEDICINE

Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials

(2008) Larry J. Dumont et al.   TRANSFUSION